NICE Ltd. NICE
Set alert
105.48 USD -6.91 -6.15%
As of Nov 3, 12:31 PM ET
104.23 Day range 108.49
83.10 52-week range 136.53
- YTD
- -6.69%
- 1 year
- -22.18%
- Open
- 107.46
- Prev close
- 112.39
- Mkt cap
- 6.05B
- Vol
- 476.75K
- Avg vol
- 537.57K
- EPS
- 6.87
- P/E
- 15.36
- Div yield
- 0.00%
More statistics
- Low
- 104.23
- High
- 108.49
- Forward P/E
- 8.87
- Beta
- 0.01
- Short ratio
- 2.26
- Inst. own
- 62.79%
- Dividend
- 0.00
- Ex-div date
- Feb 22, 2017
- Earnings
- Nov 4, 2026
- 50-d avg
- 110.66
- 200-d avg
- 105.14
- 1y target
- 132.77
1M chart
Signals (7)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Nov 3, 2026 | 3 hours ago |
| SMA: Bearish | Oct 29, 2026 | 5 days ago |
| MACD: Sell Signal | Oct 29, 2026 | 5 days ago |
| MACD: Buy Signal | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 21, 2026 | 1 week ago |
| SMA: Bearish | Oct 13, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 13, 2026 | 3 weeks ago |
Analyst view
Price target (mean) 132.77 +25.9% upside
Now 105.48
- Target (low)
- 100.00
- Target (mean)
- 132.77
- Target (high)
- 170.00
Ratings (0m) 14 9 buy · 5 hold · 0 sell
- Strong buy3
- Buy6
- Hold5
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 14
- 2 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.78 | 2.74 – 2.82 | 3.18 | -12.6% | 785.74M | +7.3% | 13 |
| Next quarter | 3.07 | 2.99 – 3.17 | 3.24 | -5.3% | 844.87M | +7.4% | 13 |
| Current year | 11.17 | 11.11 – 11.24 | 12.30 | -9.2% | 3.18B | +8.0% | 14 |
| Next year | 12.67 | 11.71 – 13.19 | 11.17 | +13.4% | 3.47B | +9.1% | 14 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 30, 2026 | Oppenheimer | Upgrade | Perform | Outperform |
| Sep 24, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 6, 2026 | DA Davidson | Maintained | Buy | Buy |
| Aug 6, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Jul 21, 2026 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Jun 18, 2026 | DA Davidson | Upgrade | Neutral | Buy |
| Jun 10, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| Jun 10, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Jun 10, 2026 | Cantor Fitzgerald | Reiterated | Neutral | Neutral |
| Jun 10, 2026 | Rosenblatt | Maintained | Buy | Buy |
| May 11, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| May 8, 2026 | Citigroup | Maintained | Neutral | Neutral |
| May 7, 2026 | DA Davidson | Maintained | Neutral | Neutral |
| May 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 7, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Apr 10, 2026 | Citigroup | Downgrade | Buy | Neutral |
| Mar 10, 2026 | DA Davidson | Maintained | Neutral | Neutral |
| Feb 20, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 20, 2026 | Wedbush | Reiterated | Neutral | Neutral |
| Feb 20, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Dec 23, 2025 | Rosenblatt | Maintained | Buy | Buy |
| Dec 8, 2025 | Wedbush | Downgrade | Outperform | Neutral |
| Nov 19, 2025 | Citigroup | Maintained | Buy | Buy |
| Nov 19, 2025 | Barclays | Maintained | Overweight | Overweight |
| Nov 18, 2025 | DA Davidson | Maintained | Neutral | Neutral |
| Nov 18, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Nov 18, 2025 | Jefferies | Maintained | Hold | Hold |
| Nov 18, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Nov 18, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 18, 2025 | Cantor Fitzgerald | Maintained | Neutral | Neutral |